The Economics of Infectious Diseases (2024)

Ahern, M., Kovats, R. S., Wilkinson, P., Few, R., & Matthies, F. (2005). Global health impacts of floods: Epidemiologic evidence. Epidemiologic Reviews, 27, 36–46.

Ahituv, A., Hotz, V. J., & Philipson, T. (1996). The responsiveness of the demand for condoms to the local prevalence of AIDS. Journal of Human Resources, 31, 869–897.

Aiken, A. M., Davey, C., Hargreaves, J. R., & Hayes, R. J. (2015). Re-analysis of health and educational impacts of a school-based deworming programme in western Kenya: A pure replication. International Journal of Epidemiology, 44, 1572–1580.

Anderson, R., & Hanson, M. (2005). Potential public health impact of imperfect HIV type 1 vaccines. Journal of Infectious Diseases, 191, S85–S96.

Anderson, R. M., May, R. M., & Anderson, B. (1992). Infectious diseases of humans: Dynamics and control. Oxford, UK: Oxford University Press.

Andrés, L., Briceño, B., Chase, C., & Echenique, J. A. (2017). Sanitation and externalities: Evidence from early childhood health in rural India. Journal of Water Sanitation and Hygiene for Development, 7, 272–289.

Anglewicz, P., & Clark, S. (2013). The effect of marriage and HIV risks on condom use acceptability in rural Malawi. Social Science & Medicine, 97, 29–40.

Arifoğlu, K., Deo, S., & Iravani, S. M. R. (2012). Consumption externality and yield uncertainty in the influenza vaccine supply chain: Interventions in demand and supply sides. Management Science, 58, 1072–1091.

Arunachalam, R., & Shah, M. (2013). Compensated for life: Sex work and disease risk. Journal of Human Resources, 48, 345–369.

Ashraf, N., Berry, J., & Shapiro, J. M. (2010). Can higher prices stimulate product use? Evidence from a field experiment in Zambia. American Economic Review, 100(5), 2383–2413.

Auld, M. C. (2003). Choices, beliefs, and infectious disease dynamics. Journal of Health Economics, 22, 361–377.

Auld, M. C. (2006). Estimating behavioral response to the AIDS epidemic. BE Journal of Economic Analysis & Policy, 5(1), 1–29.

Baird, S., Gong, E., McIntosh, C., & Özler, B. (2014). The heterogeneous effects of HIV testing. Journal of Health Economics, 37, 98–112.

Baird, S., McIntosh, C., & Özler, B. (2011). Cash or condition? Evidence from a cash transfer experiment. Quarterly Journal of Economics, 126, 1709–1753.

Baird, S. J., Garfein, R. S., McIntosh, C. T., & Özler, B. (2012). Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: A cluster randomised trial. Lancet, 379, 1320–1329.

Barham, T., & Maluccio, J. A. (2009). Eradicating diseases: The effect of conditional cash transfers on vaccination coverage in rural Nicaragua. Journal of Health Economics, 28, 611–621.

Barrett, S. (2003). Global disease eradication. Journal of the European Economic Association, 1, 591–600.

Barrett, S. (2007). The smallpox eradication game. Public Choice, 130, 179–207.

Barrett, S. (2013). Economic considerations for the eradication endgame. Philosophical Transactions of the Royal Society B: Biological Sciences, 368, 1–10.

Bauch, C. T., & Earn, D. J. D. (2004). Vaccination and the theory of games. Proceedings of the National Academy of Sciences of the United States of America, 101, 13391–13394.

Bauch, C. T., Galvani, A. P., & Earn, D. J. D. (2003). Group interest versus self-interest in smallpox vaccination policy. Proceedings of the National Academy of Sciences, 100, 10564–10567.

Benjamin-Chung, J., Abedin, J., Berger, D., Clark, A., Falcao, L., Jimenez, V., Konagaya, E., Tran, D., Arnold, B., Hubbard, A., Luby, S., Miguel, E., & Colford, J. (2015). The identification and measurement of health-related spillovers in impact evaluations: A systematic review. 3ie Systematic Review 22. London, UK: International Initiative for Evaluation (3ie).

Bennett, D. (2012). Does clean water make you dirty? Water supply and sanitation in the Philippines. Journal of Human Resources, 47, 146–173.

Berthélemy, J.-C., Gaudart, J., & Thuilliez, J. (2015). Prevention or treatment? The case of malaria. Economics Letters, 131, 16–19.

Bhattacharya, D., Dupas, P., & Kanaya, S. (2013). Estimating the impact of means-tested subsidies under treatment externalities with application to anti-malarial bednets. NBER Working Paper. Cambridge, MA: National Bureau of Economic Research.

Bishai, D., & Adam, T. (2006). Economics of public health interventions for children in developing countries. In A. M. Jones (Ed.), The Elgar companion to health economics (pp. 46ff). Cheltenham, UK: Edward Elgar Publishing.

Blower, S., & McLean, A. (1994). Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco. Science, 265, 650–654.

Boozer, M. A., & Philipson, T. J. (2000). The impact of public testing for human immunodeficiency virus. Journal of Human Resources, 35(3), 419–446.

Boucekkine, R., Desbordes, R., & Latzer, H. (2009). How do epidemics induce behavioral changes? Journal of Economic Growth, 14, 233–264.

Boulier, B. L., Datta, T. S., & Goldfarb, R. S. (2007). Vaccination externalities. B.E. Journal of Economic Analysis & Policy, 7(1) (Contributions), Article 23. http://www.bepress.com/bejeap/vol7/iss1/art23

Brisson, M., & Edmunds, W. (2003). Economic evaluation of vaccination programs: The impact of herd-immunity. Medical Decision Making, 23, 76–82.

Bump, J. B., Reich, M. R., & Johnson, A. M. (2013). Diarrhoeal diseases and the global health agenda: Measuring and changing priority. Health Policy and Planning, 28, 799–808.

Canning, D. (2006). The economics of HIV/AIDS in low-income countries: The case for prevention. Journal of Economic Perspectives, 20, 121–142.

Castillo-Riquelme, M., Chalabi, Z., Lord, J., Guhl, F., Campbell-Lendrum, D., Davies, C., & Fox-Rushby, J. (2008). Modelling geographic variation in the cost-effectiveness of control policies for infectious vector diseases: The example of Chagas disease. Journal of Health Economics, 27, 405–426.

Chan, T. Y., Hamilton, B. H., & Papageorge, N. W. (2016). Health, risky behavior and the value of medical innovation for infectious disease. Review of Economic Studies, 83, 1465–1510.

Chong, A., Gonzalez-Navarro, M., Karlan, D., & Valdivia, M. (2013). Effectiveness and spillovers of online sex education: Evidence from a randomized evaluation in Colombian public schools. Cambridge, MA: National Bureau of Economic Research.

Cohen, J., & Dupas, P. (2010). Free distribution or cost-sharing? Evidence from a randomized malaria prevention experiment. Quarterly Journal of Economics, 125, 1–45.

Cohen, J., Dupas, P., & Schaner, S. (2015). Price subsidies, diagnostic tests, and targeting of malaria treatment: Evidence from a randomized controlled trial. American Economic Review, 105, 609–645.

Cook, J., Jeuland, M., Maskery, B., Lauria, D., Sur, D., Clemens, J., & Whittington, D. (2009). Using private demand studies to calculate socially optimal vaccine subsidies in developing countries. Journal of Policy Analysis and Management, 28, 6–28.

Davey, C., Aiken, A. M., Hayes, R. J., & Hargreaves, J. R. (2015). Re-analysis of health and educational impacts of a school-based deworming programme in western Kenya: A statistical replication of a cluster quasi-randomized stepped-wedge trial. International Journal of Epidemiology, 44, 1581–1592.

Dow, W. H., & Philipson, T. (1996). An empirical examination of the implications of assortative matching on the incidence of HIV. Journal of Health Economics, 15, 735–749.

Duflo, E., Dupas, P., & Kremer, M. (2015). Education, HIV, and early fertility: Experimental evidence from Kenya. American Economic Review, 105, 2757–2797.

Dupas, P. (2009). What matters (and what does not) in households’ decision to invest in malaria prevention? American Economic Review, 99, 224–230.

Dupas, P. (2011). Health behavior in developing countries. Annual Review of Economics, 3, 425–449.

Dupas, P. (2014). Short‐run subsidies and long‐run adoption of new health products: Evidence from a field experiment. Econometrica, 82, 197–228.

Dye, C. (2014). After 2015: Infectious diseases in a new era of health and development. Philosophical Transactions of the Royal Society B: Biological Sciences, 369, 20130426.

Ellegård, L. M., Dietrichson, J., & Anell, A. (2017). Can pay-for-performance to primary care providers stimulate appropriate use of antibiotics? Health Economics, 27(1), e39–e54.

Feigin, V. (2016). Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388, 1459–1544.

Fenner, F., Henderson, D. A., Arita, I., Jezek, Z., & Ladnyi, I. D. (1988). Smallpox and its eradication. Geneva, Switzerland: World Health Organization.

Ferguson, N. (2007). Capturing human behaviour. Nature, 446, 733.

Fink, G., & Rockers, P. C. (2017). Financial incentives, targeting, and utilization of child health services: Experimental evidence from Zambia. Health Economics, 26, 1307–1321.

Fiore, J. (2017). The impact of subsidized antimalarials on treatment seeking behavior. Tulane Economics Working Paper Series. New Orleans, LA: Tulane University.

Fluegge, K. R. (2015). Using spatial disease patterns and patient-level characteristics to describe prevalence elastic behavior in treatment for latent tuberculosis infection (LTBI). Public Health Nursing, 32, 517–531.

Geoffard, P.-Y., & Philipson, T. (1996). Rational epidemics and their public control. International Economic Review, 37(3), 603–624.

Geoffard, P.-Y., & Philipson, T. (1997). Disease eradication: Private versus public vaccination. American Economic Review, 87(1), 222–230.

Gersovitz, M. (2011). HIV testing: Principles and practice. World Bank Research Observer, 26, 1–41.

Godlonton, S., Munthali, A., & Thornton, R. (2016). Responding to risk: Circumcision, information, and HIV prevention. Review of Economics and Statistics, 98, 333–349.

Godlonton, S., & Thornton, R. L. (2013). Learning from others’ HIV testing: Updating beliefs and responding to risk. American Economic Review, 103, 439–44.

Gong, E. (2015. HIV testing and risky sexual behavior. Economic Journal, 125, 32–60.

Guerra, C. A., Snow, R. W., & Hay, S. I. (2006). A global assessment of closed forests, deforestation and malaria risk. Annals of Tropical Medicine and Parasitology, 100, 189–204.

Guillon, M., & Thuilliez, J. (2015). HIV and rational risky behaviors: A systematic review of published empirical literature (1990–2013). Documents de travail du Centre d’ Économie de la Sorbonne, No 2015.65. Paris, France: Sorbonne University.

Haacker, M. (2016). The economics of the global response to HIV/AIDS. Oxford, UK: Oxford University Press.

Hall, J. (2011). Disease prevention, health care, and economics. In S. Glied & P. C. Smith (Eds.), The Oxford handbook of health economics (vol. 1, pp. 555–577). Oxford, UK: Oxford University Press.

Head, M. G., Fitchett, J. R., Cooke, M. K., Wurie, F. B., Hayward, A. C., & Atun, R. (2013). UK investments in global infectious disease research 1997–2010: A case study. Lancet Infectious Diseases, 13, 55–64.

Heister, T., Hagist, C., & Kaier, K. (2017). Resistance elasticity of antibiotic demand in intensive care. Health Economics, 26, 892–909.

Kaier, K. (2012). Economic implications of the dynamic relationship between antibiotic use and hospital-acquired infections. Value in Health, 15, 87–93.

Kaier, K., & Frank, U. (2010). Measuring the externality of antibacterial use from promoting antimicrobial resistance. PharmacoEconomics, 28, 1123–1128.

Keeling, M. J., & Rohani, P. (2008). Modeling infectious diseases in humans and animals. Princeton, NJ: Princeton University Press.

Keesing, F., Belden, L. K., Daszak, P., Dobson, A., Harvell, C. D., Holt, R. D., . . . Ostfeld, R. S. (2010). Impacts of biodiversity on the emergence and transmission of infectious diseases. Nature, 468, 647–652.

Keogh-Brown, M. R., Wren-Lewis, S., Edmunds, W. J., Beutels, P., & Smith, R. D. (2010). The possible macroeconomic impact on the UK of an influenza pandemic. Health Economics, 19, 1345–1360.

Kohler, H.-P., & Thornton, R. L. (2012). Conditional cash transfers and HIV/AIDS prevention: Unconditionally promising? World Bank Economic Review, 26, 165–190.

Kremer, M. (1996). Integrating behavioral choice into epidemiological models of AIDS. Quarterly Journal of Economics, 111, 549–573.

Kremer, M., & Glennerster, R. (2011). Improving health in developing countries. Handbook of Health Economics, 2, 201–315.

Kremer, M., & Miguel, E. (2007). The illusion of sustainability. Quarterly Journal of Economics, 122, 1007–1065.

Lagarde, M., Haines, A., & Palmer, N. (2007). Conditional cash transfers for improving uptake of health interventions in low- and middle-income countries: A systematic review. Journal of the American Medical Association, 298, 1900–1910.

Lakdawalla, D., Sood, N., & Goldman, D. (2006). HIV breakthroughs and risky sexual behavior. Quarterly Journal of Economics, 121, 1063–1102.

Laxminarayan, R., & Malani, A. (2011). Economics of infectious diseases. In S. Glied & P. C. Smith (Eds.), The Oxford handbook of health economics (vol. 1, pp. 189–205). Oxford, UK: Oxford University Press.

Magadi, M. A., & Agwanda, A. O. (2010). Investigating the association between HIV/AIDS and recent fertility patterns in Kenya. Social Science & Medicine, 71, 335–344.

Manfredi, P., & D’Onofrio, A. (2013). Modeling the interplay between human behavior and the spread of infectious diseases. New York, NY: Springer.

Mechoulan, S. (2007). Risky sexual behavior, testing, and HIV treatments. Forum for Health Economics & Policy, 10(2).

Medoff, M. H. (2012). Acquired immune deficiency syndrome, risky sexual behavior and abortion. Journal of Social Sciences, 8, 223.

Miguel, E., & Kremer, M. (2004). Worms: Identifying impacts on education and health in the presence of treatment externalities. Econometrica, 72, 159–217.

Minnis, A. M., Steiner, M. J., Gallo, M. F., Warner, L., Hobbs, M. M., Van Der Straten, A., . . . Padian, N. S. (2009). Biomarker validation of reports of recent sexual activity: Results of a randomized controlled study in Zimbabwe. American Journal of Epidemiology, 170, 918–924.

Murray, C. J. L., Barber, R. M., Foreman, K. J., Ozgoren, A. A., Abd-Allah, F., Abera, S. F., . . . Vos, T. (2015). Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: Quantifying the epidemiological transition. Lancet, 386, 2145–2191.

Norwood, M. S., Hughes, J. P., & Amico, K. R. (2016). The validity of self-reported behaviors: Methods for estimating underreporting of risk behaviors. Annals of Epidemiology, 26, 612–618.

Nyhan, B., & Reifler, J. (2015). Does correcting myths about the flu vaccine work? An experimental evaluation of the effects of corrective information. Vaccine, 33, 459–464.

O’Neill, J. (2014). Antimicrobial resistance: Tackling a crisis for the health and wealth of nations. Review on Antimicrobial Resistance, J. O’Neill (chair). London, UK: HM Government.

Oster, E. (2012). HIV and sexual behavior change: Why not Africa? Journal of Health Economics, 31, 35–49.

Outterson, K., Gopinathan, U., Clift, C., So, A. D., Morel, C. M., & Røttingen, J.-A. (2016). Delinking investment in antibiotic research and development from sales revenues: The challenges of transforming a promising idea into reality. PLOS Medicine, 13, e1002043.

Patz, J. A., Daszak, P., Tabor, G. M., Aguirre, A. A., Pearl, M., Epstein, J., . . . Molyneux, D. (2004). Unhealthy landscapes: Policy recommendations on land use change and infectious disease emergence. Environmental Health Perspectives, 112, 1092.

Paula, Á. D., Shapira, G., & Todd, P. E. (2014). How beliefs about HIV status affect risky behaviors: Evidence from Malawi. Journal of Applied Econometrics, 29, 944–964.

Philipson, T. (1996). Private vaccination and public health: An empirical examination for U.S. measles. Journal of Human Resources, 31, 611–630.

Philipson, T. (2000). Economic epidemiology and infectious diseases. Handbook of Health Economics, 1, 1761–1799.

Philipson, T., & Posner, R. (1993). Private choices and public health: An economic interpretation of the AIDS epidemic. Cambridge, MA: Harvard University Press.

Picone, G., Kibler, R., & Apouey, B. H. (2017). Malaria prevalence, indoor residual spraying, and insecticide-treated net usage in sub-Saharan Africa. Journal of African Development, 19, 19–32.

Pisani, E. (2010). The wisdom of whor*s: Bureaucrats, brothels and the business of AIDS. London, UK: Granta Books.

Pitman, R., Fisman, D., Zaric, G. S., Postma, M., Kretzschmar, M., Edmunds, J., & Brisson, M. (2012). Dynamic transmission modeling: A report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5. Value in Health, 15, 828–834.

Renwick, M. J., Brogan, D. M., & Mossialos, E. (2016). A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics. Journal of Antibiotics, 69, 73.

Sabot, O., Cohen, J. M., Hsiang, M. S., Kahn, J. G., Basu, S., Tang, L., . . . Feachem, R. G. A. (2010). Costs and financial feasibility of malaria elimination. Lancet, 376, 1604–1615.

Sands, P., Mundaca-Shah, C., & Dzau, V. J. (2016). The neglected dimension of global security—A framework for countering infectious-disease crises. New England Journal of Medicine, 374, 1281–1287.

Schmid, P., Rauber, D., Betsch, C., Lidolt, G., & Denker, M.-L. (2017). Barriers of influenza vaccination intention and behavior—A systematic review of influenza vaccine hesitancy, 2005–2016. PLOS One, 12, e0170550.

Shim, E., Chapman, G. B., Townsend, J. P., & Galvani, A. P. (2012). The influence of altruism on influenza vaccination decisions. Journal of the Royal Society Interface, rsif20120115.

Skåtun, J. D. (2003). The overprovision of infectious disease medicine. Economics Letters, 80, 61–66.

Smith, R., & Coast, J. (2012). The economic burden of antimicrobial resistance: Why it is more serious than current studies suggest. London, UK: London School of Hygiene & Tropical Medicine.

Smith, R., & Coast, J. (2013). The true cost of antimicrobial resistance. BMJ, 346, f1493.

Staben, R. (2016). Testing the prevalence elasticity of demand for HPV vaccination. Working paper. Stanford, CA: Department of Economics, Stanford University.

Stenberg, K., Axelson, H., Sheehan, P., Anderson, I., Gülmezoglu, A. M., Temmerman, M., . . . Bustreo, F. (2014). Advancing social and economic development by investing in women’s and children’s health: A new global investment framework. Lancet, 383, 1333–1354.

Stiglitz, J. E. (1988). Economics of the public sector New York, NY: W. W. Norton & Company.

Tarozzi, A., Mahajan, A., Yoong, J., & Blackburn, B. (2009). Commitment mechanisms and compliance with health-protecting behavior: Preliminary evidence from Orissa, India. American Economic Review, 99, 231–235.

Thornton, R. L. (2008). The demand for, and impact of, learning HIV status. American Economic Review, 98, 1829–63.

Verelst, F., Willem, L., & Beutels, P. (2016). Behavioral change models for infectious disease transmission: A systematic review (2010–2015). Journal of The Royal Society Interface, 13.

Walker, C. L. F., Friberg, I. K., Binkin, N., Young, M., Walker, N., Fontaine, O., . . . Black, R. E. (2011). Scaling up diarrhea prevention and treatment interventions: A lives saved tool analysis. PLOS Medicine, 8, e1000428.

Ward, C. J. (2014). Influenza vaccination campaigns: Is an ounce of prevention worth a pound of cure? American Economic Journal: Applied Economics, 6, 38–72.

Watson, T. (2006). Public health investments and the infant mortality gap: Evidence from federal sanitation interventions on U.S. Indian reservations. Journal of Public Economics, 90, 1537–1560.

Weston, D., Hauck, K., & Amlôt, R. (2018). Infection prevention behaviour and infectious disease modelling: A review of the literature and recommendations for the future. BMC Public Health, 18, 336.

Wilson, N. L., Xiong, W., & Mattson, C. L. (2014). Is sex like driving? HIV prevention and risk compensation. Journal of Development Economics, 106, 78–91.

World Health Organization (WHO). (2017a). Antibacterial agents in clinical development: An analysis of the antibacterial clinical development pipeline, including tuberculosis. Geneva, Switzerland: World Health Organization.

World Health Organization (WHO). (2017b). Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Geneva, Switzerland: World Health Organization.

Young, A. (2007). In sorrow to bring forth children: Fertility amidst the plague of HIV. Journal of Economic Growth, 12, 283–327.